6 Jan 2022 07:00
6 January 2022
DeepVerge PLC
("DeepVerge" or "Company")
Microtox water testing equipment installed ahead of Beijing 2022 Winter Olympics
DeepVerge (LSE:DVRG.L), announces that its environmental division, Modern Water, has completed installation of Microtox® Continuous Toxicity Monitor ("CTM") permanent units and Microtox® FX portable laboratory units in Beijing, China, ahead of the athletes arriving at the 2022 Winter Olympics Village.
Microtox® CTM is a site-based, broad range Continuous Toxicity Monitor that continuously measures the chemical toxicity of a water source, giving instant indication of water health. It is a fully automatic instrument that offers a 4-week, autonomous operating cycle and requires a low level of skill for both operation and maintenance.
Microtox® FX has a combined detection capability that provides a very sensitive and rapid test to detect two of the most probable classes of agents, pathogens and toxic chemicals that may accidentally or intentionally contaminate drinking water or wastewater. Microtox® FX's acute toxicity and ATP (adenosine triphosphate) detection capabilities make it the ideal instrument for rapidly and accurately assessing if the quality of drinking water, from the source to the tap, has been affected by an incident.
Gerard Brandon, CEO of DeepVerge plc, commented:
"Once again, water suppliers to the Olympic Games have placed their trust, and the safety of athletes and officials, in the hands of Modern Water. The company's Microtox® toxicity testing has been used at every Olympics competition since Los Angeles 1984, apart from last year's Tokyo Olympics because of travel restrictions. With the Covid-19 pandemic still affecting much of the world, the importance of identifying pathogens in water can't be overstated, which is why Modern Water is working with governments to help track the virus and even predict where future outbreaks could occur."
DeepVerge plc | Gerry Brandon | +44 (0) 7340 055 648 |
SPARK Advisory Partners Limited (Nominated Adviser) | Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/James Pope | +44 (0) 20 3657 0050 |
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments and the data they generate, for the analysis and identification of bacteria, virus and toxins. DeepVerge is utilising artificial intelligent data analytics to prove scientifically the impact of skincare product claims on the skin microbiome for clients including most of the top 20 global cosmetic companies and to detect remotely, and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.
About Reach announcements
Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.